2. Gillis C, Ljungqvist O, Carli F. Corrigendum to 'Prehabilitation, enhanced recovery after surgery, or both? A narrative review' (Br J Anaesth 2022; 128: 434-48). Br J Anaesth 2022;128:1061.
5. Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, et al. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc 2020;21:300–7.
8. Derstine BA, Holcombe SA, Goulson RL, Ross BE, Wang NC, Sullivan JA, et al. Quantifying sarcopenia reference values using lumbar and thoracic muscle areas in a healthy population. J Nutr Health Aging 2017;21:180–5.
10. Sinelnikov A, Qu C, Fetzer DT, Pelletier JS, Dunn MA, Tsung A, et al. Measurement of skeletal muscle area: comparison of CT and MR imaging. Eur J Radiol 2016;85:1716–21.
13. Shen Y, Chen J, Chen X, Hou L, Lin X, Yang M. Prevalence and associated factors of sarcopenia in nursing home residents: a systematic review and meta-analysis. J Am Med Dir Assoc 2019;20:5–13.
14. Pamoukdjian F, Bouillet T, Lévy V, Soussan M, Zelek L, Paillaud E. Prevalence and predictive value of pre-therapeutic sarcopenia in cancer patients: a systematic review. Clin Nutr 2018;37:1101–13.
16. Huang DD, Wang SL, Zhuang CL, Zheng BS, Lu JX, Chen FF, et al. Sarcopenia, as defined by low muscle mass, strength and physical performance, predicts complications after surgery for colorectal cancer. Colorectal Dis 2015;17:O256–64.
19. Bano G, Trevisan C, Carraro S, Solmi M, Luchini C, Stubbs B, et al. Inflammation and sarcopenia: a systematic review and meta-analysis. Maturitas 2017;96:10–5.
20. Francomacaro LM, Walker C, Jaap K, Dove J, Hunsinger M, Widom K, et al. Sarcopenia predicts poor outcomes in urgent exploratory laparotomy. Am J Surg 2018;216:1107–13.
21. McQuade C, Kavanagh DO, O'Brien C, Hunter K, Nally D, Hickie C, et al. CT-determined sarcopenia as a predictor of post-operative outcomes in patients undergoing an emergency laparotomy. Clin Imaging 2021;79:273–7.
23. Du Y, Karvellas CJ, Baracos V, Williams DC, Khadaroo RG; Acute Care and Emergency Surgery (ACES) Group. Sarcopenia is a predictor of outcomes in very elderly patients undergoing emergency surgery. Surgery 2014;156:521–7.
27. Voron T, Tselikas L, Pietrasz D, Pigneur F, Laurent A, Compagnon P, et al. Sarcopenia impacts on short- and long-term results of hepatectomy for hepatocellular carcinoma. Ann Surg 2015;261:1173–83.
32. Reisinger KW, Derikx JP, van Vugt JL, Von Meyenfeldt MF, Hulsewé KW, Olde Damink SW, et al. Sarcopenia is associated with an increased inflammatory response to surgery in colorectal cancer. Clin Nutr 2016;35:924–7.
33. Abbass T, Dolan R, McSorley ST, Horgan PG, McMillan DC. Association of sarcopenia and myosteatosis with the systemic inflammatory response and tumor stage in patients undergoing surgery for colorectal cancer (CRC). J Clin Oncol 2020;38(4_suppl):130.
36. Antoun S, Borget I, Lanoy E. Impact of sarcopenia on the prognosis and treatment toxicities in patients diagnosed with cancer. Curr Opin Support Palliat Care 2013;7:383–9.
41. Jain SR, Kandarpa VL, Yaow CY, Tan WJ, Ho LM, Sivarajah SS, et al. The role and effect of multimodal prehabilitation before major abdominal surgery: a systemic review and meta-analysis. World J Surg 2023;47:86–102.
42. Gillis C, Buhler K, Bresee L, Carli F, Gramlich L, Culos-Reed N, et al. Effects of nutritional prehabilitation, with and without exercise, on outcomes of patients who undergo colorectal surgery: a systematic review and meta-analysis. Gastroenterology 2018;155:391–410.e4.
46. Morielli AR, Usmani N, Boulé NG, Severin D, Tankel K, Joseph K, et al. Feasibility, safety, and preliminary efficacy of exercise during and after neoadjuvant rectal cancer treatment: a phase II randomized controlled trial. Clin Colorectal Cancer 2021;20:216–26.
48. de Klerk M, van Dalen DH, Nahar-van Venrooij LM, Meijerink WJ, Verdaasdonk EG. A multimodal prehabilitation program in high-risk patients undergoing elective resection for colorectal cancer: a retrospective cohort study. Eur J Surg Oncol 2021;47:2849–56.
50. Tan S, Meng Q, Jiang Y, Zhuang Q, Xi Q, Xu J, et al. Impact of oral nutritional supplements in post-discharge patients at nutritional risk following colorectal cancer surgery: a randomised clinical trial. Clin Nutr 2021;40:47–53.
52. Kobayashi H. Amino acid nutrition in the prevention and treatment of sarcopenia. Yakugaku Zasshi 2018;138:1277–83. Japanese.
54. Koh FH. Oral nutritional supplementation with HMB enhance muscle quality in sarcopenic surgical patients (HEROS). ClinicalTrials.gov identifier: NCT05344313 [Internet]. US National Library of Medicine; 2022 [cited 2022 Dec 20]. Available from:
https://clinicaltrials.gov/ct2/show/NCT05344313
60. Bruns ER, Argillander TE, Van Den Heuvel B, Buskens CJ, Van Duijvendijk P, Winkels RM, et al. Oral nutrition as a form of pre-operative enhancement in patients undergoing surgery for colorectal cancer: a systematic review. Surg Infect (Larchmt) 2018;19:1–10.
68. Liu JC, Dong SS, Shen H, Yang DY, Chen BB, Ma XY, et al. Multi-omics research in sarcopenia: current progress and future prospects. Ageing Res Rev 2022;76:101576.